CTRI/2022/01/039577
Completed
Phase 4
CLINICAL EVALUATION OF EFFICACY AND LONGEVITY OF NANOSEAL AND ADMIRA PROTECT DESENSITIZING AGENTS ON REDUCING DENTINE HYPERSENSITIVITY AFTER SINGLE DOSE APPLICATION.A RANDOMIZED, SPLIT MOUTH CLINICAL TRIAL.
ESWARI PRIYA GUMMADI0 sites55 target enrollmentTBD
Overview
- Phase
- Phase 4
- Intervention
- Not specified
- Conditions
- Health Condition 1: K030- Excessive attrition of teeth
- Sponsor
- ESWARI PRIYA GUMMADI
- Enrollment
- 55
- Status
- Completed
- Last Updated
- 3 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patients with age ranged from 18\-50 years, with the presence of at least 1 sensitive molar each, in at least two quadrants, with a Schiff cold air sensitivity score of \>\=2 on occlusal surfaces of attrited molars, that are not going to be planned to receive any restorations are going to be included in the study.
Exclusion Criteria
- •Patients who are already using desensitizing agents, teeth with Abrasions, Erosions, Cracked enamel, Carious lesions, Defective restorations, Pathology of pulp.
- •Patients with active Periodontal disease and patients using medication with analgesic drugs.
- •Pregnant or lactating women, and patients with eating disorders and regurgitation or chronic diseases are going to be excluded from the study.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Phase 2
Dashang aerosol spray in operated piles pain managementCTRI/2022/06/043585PARUL INSTITUTE OF AYURVEDA
Recruiting
Phase 1
Clinical study on the new orthodontic anchor screwMalocclusionObstacle of the supporting tissue of other teeth and the toothJPRN-jRCTs032180394Moriyama Keiji10
Completed
Not Applicable
An investigation of the clinical effectiveness of fixing the probe to the skin during ultrasound-guided central venous cannulation.Patients undergoing central venous cannulationJPRN-UMIN000009237Hirosaki University Graduate School of Medicine280
Completed
Not Applicable
Clinical evaluation of the efficacy and safety of Hochuekkito for fatigue in patients with myeloproliferative neoplasmsmyeloproliferative neoplasmsJPRN-UMIN000031519Department of Hematology, Juntendo University School of Medicine110
Recruiting
Early Phase 1
Clinical evaluation of the efficacy and safety of Huayu Tongbi Fomular on rheumatoid arthritisRheumatoid ArthritisITMCTR2024000092Guangdong Provincial Hospital of Chinese Medicine